← Eichor
Study identifier: NCT04069091 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Implementation of Prevention and Intervention of Maternal Perinatal Depression to Strengthen Maternal and Child Health

Condition: Perinatal Depression  ·  Sponsor: Katri Räikkönen

PhaseNA
Planned participants1000
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

IMPRINT strengthens maternal and child health by screening, treating and preventing maternal perinatal depression, the most common complication of pregnancy and the child's first 1000 days. It is associated with poor pregnancy outcome and perinatal mortality and has adverse consequences on physical and mental development of the child. Yet, only 7-28% of women with perinatal depression worldwide receive appropriate evidence-based care. This is astounding given that the need of investing on mental health is widely recognized and low-intensity interventions not requiring costly mental health professionals have been shown to be effective. IMPRINT improves the effectiveness, reliability, safety, appropriateness, equity and efficiency of routine health care provided for the mother and the child during the child's first 1000 days of life. The investigators 1) have adapted into the gender-, country-, and cultural-context an existing evidence-based, low-intensity pregnancy intervention targeting maternal perinatal depression (online CBT-based therapy) (iloodottaa.fi); 2) test in cluster-randomised trial the short- and long-term efficacy of the intervention in women who report clinically relevant, subthreshold or more severe symptoms in an early pregnancy depression screen; 3) study biological, psychological and social determinants of depressive symptom severity, comorbidities and response to interventions. The study recruits women from 58 antenetal clinics in the cities of Helsinki, …

This description comes directly from the study's public registry record.

Talk to the study team

Katri Räikkönen, PhD  ·  +358405121469  ·  katri.raikkonen@helsinki.fi

Jaana Palukka, PhD  ·  +3580452783969  ·  tutkimushoitaja@iloodottaa.fi

Always discuss trial participation with your own doctor first.

Locations (1)

University of HelsinkiHelsinki, Uusimaa, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04069091